Researcher ORCID Identifier
https://orcid.org/0009-0007-4172-0812
Graduation Year
2026
Date of Submission
12-2025
Document Type
Open Access Senior Thesis
Degree Name
Bachelor of Arts
Department
Economics
Reader 1
Professor Benjamin Gillen
Rights Information
2025 Sofia K Weinstein
Abstract
This thesis examines how investors react to biotechnology firms’ clinical trial announcements and whether artificial intelligence (AI) can enhance our understanding of those market reactions. Using a representative sample of 95 firm-event observations between 2014 and 2025, the study measures cumulative abnormal returns (CARs) surrounding clinical readouts, regulatory decisions, and partnership disclosures. Event-study regressions test for heterogeneity across trial phase, therapeutic area, and textual sentiment derived from company press releases. Consistent with expectations, later-phase trials, particularly Phase II and III, produce stronger short-term abnormal returns. However, categorical variables such as phase or therapeutic area explain little of the total variation in market reactions (R² values remain below 0.15). Instead, qualitative tone extracted from press releases proves more informative: AI-based sentiment classification significantly predicts the direction and magnitude of CARs. Positive tones (“exceeded expectations”) correspond to CARs around +0.4%, while negative tones (“fell short”) are associated with small, directionally negative moves that are rarely statistically significant. These results suggest that market responses to biotech events are driven less by structural categories and more by the tone of how information is communicated. The findings support a hybrid interpretation of market efficiency: investors process technical information rapidly but rely heavily on linguistic cues to interpret complex outcomes. By integrating text-based machine learning with traditional event-study methods, this thesis demonstrates how large language models can improve empirical modeling of investor behavior in high-uncertainty industries.
Recommended Citation
Weinstein, Sofia K., "Investor Reactions to Clinical Trial Outcomes: Interpreting Impacts using AI-based measures of Investor Sentiment" (2026). CMC Senior Theses. 4301.
https://scholarship.claremont.edu/cmc_theses/4301